The regulation of CCAAT/enhancer-binding protein-homologous protein (CHOP), an endoplasmic reticulum (ER) stress-response factor, is key to cellular survival. Hypoxia is a physiologically important stress that induces cell death in the context of the ER, especially in solid tumors. Although our previous studies have suggested that Cyclophilin B (CypB), a molecular chaperone, has a role in ER stress, currently, there is no direct information supporting its mechanism under hypoxia. Here, we demonstrate for the first time that CypB is associated with p300 E4 ligase, induces ubiquitination and regulates the proteasomal turnover of CHOP, one of the well-known pro-apoptotic molecules under hypoxia. Our findings show that CypB physically interacts with the N-terminal a-helix domain of CHOP under hypoxia and cooperates with p300 to modulate the ubiquitination of CHOP. We also show that CypB is transcriptionally induced through ATF6 under hypoxia. Collectively, these findings demonstrate that CypB prevents hypoxia-induced cell death through modulation of ubiquitin-mediated CHOP protein degradation, suggesting that CypB may have an important role in the tight regulation of CHOP under hypoxia.
CCAAT/enhancer-binding protein-homologous protein (CHOP) is thought to have a role in endoplasmic reticulum (ER) stress-induced apoptosis. Furthermore, overexpression of CHOP leads to decrease in the Bcl-2 protein, and overexpression of Bcl-2 blocks CHOP-induced apoptosis. 1, 2 It is a leucine-zipper transcription factor that is present at low levels under normal conditions but is highly upregulated in ER stress by ATF4. [3] [4] [5] [6] Increased expression of CHOP promotes cell death, but the deletion of the CHOP gene leads to an attenuation in cell death induced by ER stress. 2, 7 Also, the accumulation of CHOP protein during ER stress has been reported to be regulated through modulation of its degradation by the proteasome. 8 However, recently it has been reported that CHOP is not uniformly essential for cell death induced by ER stress, although CHOP is clearly important in many scenarios of apoptosis. 9 Therefore, how CHOP mediates apoptosis has not been clearly understood yet. Recently, we showed that Cyclophilin B (CypB) blocks Ca 2 þ leakage from the ER to cytosol against the ER stress-inducing drug, thapsigargin (Ca 2 þ ATPase (SERCA) blocker), and ultimately prevents cell death in response to ER stress. 10 However, the exact molecular mechanism by which CypB protects against ER stress is still elusive.
The aim of this study was to explore the possible functional mechanisms underlying CypB in ER stress-induced apoptosis under hypoxia in terms of CHOP. We have shown that hypoxia transcriptionally upregulates CypB through ATF6. CypB interacts with CHOP, one of the best-characterized proapoptotic molecules, leading to its p300-mediated ubiquitination and degradation. Subsequently, elevated CypB shows protective effects against hypoxia-induced cell death. In addition, we found that knockdown of CypB could not prevent ER-associated apoptotic signaling under hypoxia. These results suggest that CypB might be another key molecule in the adaptation to hypoxia.
Results
CypB interacts with CHOP and promotes polyubiquitination of CHOP under hypoxia. First, we monitored the expression levels of proteins involved in hypoxia-induced cell death in CypB-overexpressing cells under hypoxia.
Intriguingly, the expression level of CHOP was significantly decreased. As shown in Figure 1a , the expression level of CHOP protein was decreased by CypB expression in a dosedependent manner. However, hypoxia still induced CHOP mRNA expression independently of CypB overexpression ( Figure 1a , lower panel). These results suggest that CypB may modulate the protein stability of CHOP, but not its transcription level. To investigate in detail whether endogenous CypB contributes to the regulation of CHOP physiologically, we produced AGS cells depleted of endogenous CypB using siRNA for dose-dependent silencing of CypB expression. Importantly, the level of CHOP protein was increased when CypB was silenced under hypoxia, but not with control siRNA (Figure 1b) . These results indicate that CypB may regulate the levels of endogenous CHOP.
To gain greater insight into the function of CypB in CHOP regulation, we investigated whether CypB participates in the proteasomal degradation pathway of the CHOP protein.
As shown in Figure 1c Figure 1d , the halflife of CHOP protein was longer in CypB siRNA-treated cells compared with control siRNA-treated cells under hypoxia after treatment with cycloheximide (CHX). As CHOP protein is reportedly degraded by ubiquitination, 11 we monitored the involvement of CypB in the ubiquitination and degradation of CHOP. AGS cells were transfected with CypB siRNA and CHOP ubiquitination was monitored by western blot. As shown in Figure 1e , lanes 2 and 4, overexpression of CypB facilitated the ubiquitination of endogenous CHOP. To confirm these results, we repeated these experiments with CypB siRNA-treated cells. siRNA-mediated inhibition of CypB led to a significant decrease in ubiquitination and an increase in the stabilization of CHOP (Figure 1f ). Together, these results suggest that CypB may modulate CHOP degradation.
Next, we tested for a physical interaction between CHOP and CypB by coimmunoprecipitation in human embryonic kidney (HEK)293 QBI cells. We performed coimmunoprecipitation experiments after inducing the expression of endogenous CypB-CHOP complex under hypoxia in HEK293 QBI cells without exogenous protein expression. The specific CypB-CHOP interaction was checked in immunoprecipitates using anti-CypB. Figure 2a shows the endogenous specific CypB-CHOP complex under hypoxia.
After cotransfection with HA-CypB and Flag-CHOP constructs, HA antibody was used to immunoprecipitate exogenous HA-CypB, and Flag antibody or HA antibody was used to probe the immunoprecipitates on immunoblots. Flag-CHOP was found to coimmunoprecipitate with HA-CypB in the presence of MG132 (Figure 2b ). Intriguingly, we could not show any significantly weaker interaction between Flag-CHOP and PPIase-defective CypB R95A mutant, suggesting that PPIase activity of CypB is not necessary for this physical binding (Figure 2c) . CHOP is present in the cytosol under nonstressed conditions, and stress leads to the induction of CHOP and its accumulation in the nucleus. 12 To confirm the interaction between CypB and CHOP in vivo, we examined the subcellular distribution of CypB and CHOP using confocal microscopy. AGS cells were transfected with HA-CypB and Flag-CHOP expression vector. The immunofluorescence analysis shows that CypB mainly colocalized with CHOP, but not completely, as shown in a merged image (Figure 2d , left panel). We repeated the colocalization experiment with endogenous CHOP and CypB in AGS cells under hypoxia. Consistently, the majority of endogenous CHOP colocalized with CypB under hypoxia (Figure 2d, right panel) . To further study the interaction of CypB and CHOP, we used a set of deletion mutants of Myc-CHOP to coimmunoprecipitate with Flag-CypB in HEK293 QBI cells ( Figure 2e ). As shown in Figure 2f , wild-type CHOP (WT), CHOPDBR (lacking whole-DNA-binding domain) and CHOPDLZ (lacking leucine zipper domain) were tested to interact with CypB. However, CHOPDN36 (lacking a-helix domain) failed to interact with CypB, suggesting that N-terminal region of CHOP containing a-helix domain is necessary for the interaction. These results were confirmed by performing the GST-pulldown assay ( Figure 2g ). Also, in order to address whether the N-terminal region of CHOP is necessary for its degradation by proteasome, degradation of CHOPDN36 was monitored with increased expression levels of CypB. As shown in Figure 2h , the protein stability level of WT CHOP protein was decreased by CypB expression in a dose-dependent manner, but not CHOPDN36, suggesting that N-terminal region of CHOP is necessary for its degradation. Next, we examined whether CypB and N-terminal region of CHOP are associated with polyubiquitination of CHOP. Consistent with the protein stability results, WT CHOP, CHOPDBR and CHOPDLZ were easily ubiquitinated; however, CHOPDN36 was not readily ubiquitinated under the same conditions ( Figure 2i ). Taken together, our results suggest that CypB facilitates CHOP polyubiquitination through its binding to the N-terminal a-helix domain of CHOP.
CypB facilitates CHOP ubiquitination in a p300-dependent manner. Previously p300 was reported to be a crucial factor for the degradation of p53 as E4 ligase. 13 The N-terminal region of CHOP necessary for its degradation was also essential for its interaction with p300. 8 Therefore, we hypothesized that CypB might affect p300-dependent ubiquitination of CHOP. Given that p300 can act as an E4 for CHOP, the interaction between CHOP and p300 was analyzed by immunoprecipitation in hypoxia-induced HEK293 QBI cells treated with MG132 after HA-p300 and Flag-CypB overexpression. About two folds of CHOP was found to coimmunoprecipitate with HA-p300 after Flag-CypB overexpression compared with before, indicating that overexpression of CypB increased the interaction between CHOP and p300 ( Figure 3a) . We also repeated similar experiments in CypB knockdown. As shown in Figure 3b , CHOP binding to p300 was almost abolished in CypB knockdown in the presence of MG132. To further examine whether p300 affects the interaction between CypB and CHOP, we repeated the immunoprecipitation using p300 knockdown. Intriguingly, p300 knockdown significantly reduced CypB binding to CHOP in the presence of MG132 (Figure 3c ). To further characterize the interactions among CypB, p300, and CHOP, coimmunoprecipitation experiment with endogenous CypB protein was performed in the presence of MG132 under hypoxia. Endogenous p300 was found to coimmunoprecipitate with endogenous CypB, suggesting that CypB and p300 physically interact with each other (Supplementary Figure 1A) . Also, we repeated the coimmunoprecipitation experiment with endogenous p300. We successfully demonstrated that endogenous CHOP and CypB are precipitated with endogenous p300, suggesting that CypB, p300 and CHOP form a complex (Supplementary Figure 1B) . Taken altogether, these results suggest that CypB and p300 cooperately bind to CHOP under hypoxia.
Consistently, the introduction of CypB markedly facilitated p300-mediated ubiquitination of CHOP (Figure 3d Modulation of CHOP stability by CypB is not dependent on ATF4 under hypoxia. It has been reported that ATF4 is overexpressed under hypoxia, 14 and that it can directly upregulate CHOP transcription through its binding to the CHOP promoter region. 5, 6 Thus, we tested whether hypoxia increases ATF4 and CHOP expression in our cell lines. Both ATF4 and CHOP protein levels began to increase after 3 h in hypoxia (Figure 4a ), and continuously increased for up to 12 h (experimental endpoint). However, Bcl-2 expression was suppressed in a time-dependent manner under hypoxia. Next, we transfected AGS cells with the WT CHOP promoter (CHOP-777) in order to assess whether hypoxia induces the CHOP promoter through ATF4-binding sites. As expected, the WT CHOP promoter (CHOP-777) showed a significantly increased luciferase activity under hypoxia, compared with normoxia ( Figure 4b Figure 2D) . We also monitored the transcriptional effects of CypB on CHOP mRNA under hypoxia in ATF knockdown or CypB knockdown (Supplementary Figures 2E and F). Our data confirmed again that ATF4 but not CypB transcriptionally upregulates CHOP under hypoxia. In order to confirm that CypB modulates CHOP stability in an ATF4-independent manner under hypoxia, we performed the immunoprecipitation experiment ( Figure 4g ). As expected, overexpression of CypB reduced CHOP expression, whether ATF4 was overexpressed or not ( Figure 4g , compare lanes 2 and 6 with lanes 4 and 8, respectively).
Hypoxia-mediated induction of CypB requires ATF6. Next, the CypB protein level was monitored in AGS cells under hypoxia. CypB protein expression was significantly increased under hypoxia (Figure 5a ). A time-course experiment showed that CypB protein expression under hypoxia reached a maximum level after 12 h and was sustained until 24 h. These results were confirmed by immunocytochemical observation. Calnexin, a calcium-binding protein, was used as an ER marker. Increased CypB expression was shown in the ER lumen of AGS cells after a 24-h exposure to hypoxia The role of CypB in CHOP ubiquitination K Jeong et al ( Figure 5b ). Densitometric analysis showed that CypB expression was increased by more than twofold under hypoxia, suggesting a crucial role of CypB in hypoxia. The hypoxic condition also physiologically occurs in brain ischemia. We used bilateral common carotid artery occlusion (BCCAO) to monitor neuronal CypB in ischemia-induced hippocampus. The expression of both CypB and glucoserelated protein (GRP) 78 in the dentate gyrus subfields was studied using immunohistochemical analysis (Figure 5c ). GRP78 was used as an ER marker. One week after BCCAO, CypB protein expression had increased by 2.5-fold in the dentate gyrus subfields in ischemia-operated mice compared with sham-operated mice. GRP78 protein expression was also strongly increased in ischemia-operated mice. These results suggest that CypB expression is upregulated by hypoxia in many kinds of cells.
To determine whether CypB is regulated by p50ATF6 or spliced XBP1 (sXBP1) at the transcriptional level under hypoxia, we transiently cotransfected AGS cells with ATF6-or sXBP1-transcription factor expression plasmids and pGL3-CypB-250 plasmid and analyzed the luciferase activity of these transfected cells (Figure 6a, upper panel) . p50ATF6 expression plasmids increased the luciferase activity in the transfected cells dose-dependently compared with cells transfected with the pcDNA control vector, but sXBP1 expression plasmids did not (Figure 6a, upper right panel) .
Western blot showed that CypB protein expression is increased by p50ATF6 in a dose-dependent manner, but not by sXBP1 expression plasmids (Figure 6a, lower panel) .
To determine whether the ATF6 binding site is associated with hypoxia-induced transcriptional upregulation, the ATF6 binding site was mutated from 'cgtgg' to 'cacag' by site-directed mutagenesis in the pGL3-CypB-250 plasmid (Figure 6b ). The mutated ATF6 binding site markedly abolished hypoxia-induced transcriptional activation of CypB promoter, indicating that ATF6 has a crucial role in hypoxiainduced transcriptional activation of CypB. To confirm these results, the binding of ATF6 to the CypB promoter under To confirm the crucial roles of the ATF6 pathway in hypoxia, a selective inhibitor of ATF6, 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), was used. AEBSF is a serine protease inhibitor and prevents ER stress-induced cleavage of p90ATF6. 15 The real-time PCR analysis also showed that both ATF6 mRNA (Figure 6e, left panel) and CypB mRNA levels were decreased by AEBSF under hypoxia (Figure 6f , right panel). Consistently, hypoxia-induced CypB luciferase activity was decreased in the presence of AEBSF, compared with the absence of AEBSF (Figure 6f , left panel). Western blot showed that AEBSF efficiently blocks p90ATF6 cleavage and inhibits hypoxia-mediated induction of CypB (Figure 6f , right panel). Interestingly, downregulation of CypB by AEBSF increased hypoxia-induced cell death compared with the absence of AEBSF (Figure 6g ). Also, ChIP assay demonstrated that AEBSF abrogated the hypoxia-stimulated ATF6 recruitment to the CypB promoter (element B), but not to an irrelevant site (element A; Figure 6h ). Taken together, these results suggest a crucial role for ATF6 in the induction of CypB under hypoxia.
Overexpressed CypB inhibits hypoxia-induced apoptosis via ER stress-dependent pathway. To explore the role of CypB in hypoxia-induced cell death, we monitored DNA fragmentation by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay. As expected, CypB expression inhibited hypoxia-induced DNA fragmentation compared with pcDNA control vector (Figure 7a, upper panel) . As shown by western blot analysis, the expression of cleaved caspase-3 and anti-poly (ADP ribose) polymerase (PARP) was almost suppressed by overexpressed CypB under hypoxia (Figure 7a, lower panel) . These observations were further confirmed by flow cytometry (FACS) analysis (Figure 7b ), the clonogenic assay ( Figure 7c ) and CypB knockdown experiments (Figure 7d) . In order to examine whether CypB knockdown may cause ER stress-induced apoptosis under hypoxia, several apoptosis markers were monitored. Knockdown of CypB increased the expression levels of cleaved caspase3, PARP, Bax, GRP78, p-eIF2a, and decreased Bcl-2 expression compared with negative control siRNA in hypoxia (Figure 7e) . Also, we monitored CHOP activation in CypB knockdown-induced apoptosis under hypoxia. CHOP was easily detected in the nucleus of apoptotic cells in CypB knockdown by RNA interference, but not in the cells with the negative control siRNA in hypoxia (Figure 7f ). Taken together, these results indicate that CypB knockdown increased hypoxia-induced apoptosis through an ER stressdependent pathway.
Finally, in order to investigate whether CypB and CHOP are controlling cell death on a linear pathway, we performed a double knockdown of CypB and CHOP in AGS cells Figure 3) . The double knockdown cells were incubated under hypoxia for 48 h and subjected to the trypan blue exclusion assay. CypB knockdown showed a significant increase in apoptotic cells compared with control siRNA-transfected cells under hypoxia.
However, CHOP knockdown showed a significant decrease in apoptotic cells, compared with control siRNA-transfected cells under hypoxia. These results suggest that CypB has an antiapoptotic role, whereas CHOP seems to function as a proapoptotic factor in our cell system. The double knockdown showed a similar level of cell death compared with CHOP
The role of CypB in CHOP ubiquitination K Jeong et al knockdown under hypoxia, but a significant decrease compared with CypB knockdown under hypoxia. Our data suggest that CypB and CHOP control hypoxia-induced cell death on a linear pathway.
Discussion
The transcription factor CHOP is one of the best-characterized pro-apoptotic molecules accounting for ER stressinduced cell death. However, little is known about the interaction of CypB and CHOP under hypoxia. Here, we demonstrated that CypB and p300 cooperatively interacts with CHOP, leading to ubiquitination of CHOP and inhibition of hypoxia-induced apoptosis.
In the current study, we found that hypoxia significantly upregulated CypB mRNA expression in a time-dependent and an ATF6-dependent manner ( Figure 6 ). This is inconsistent with the results of a previous report showing that HIF-1a transcriptionally upregulates CypB under hypoxia. 16 Thus, it is possible that hypoxia-mediated CypB gene induction is due, at least in part, to HIF-1a activation. However, under the conditions employed in this study, a site-directed mutagenesis in the ATF6 binding site prevented hypoxia-induced upregulation of CypB. CypB upregulation in ATF6 knockdown cells by siATF6 was significantly impaired. Finally, we could demonstrate that AEBSF, an ATF6 inhibitor, could not induce CypB expression under hypoxia ( Figure 6 ). Also, these results are consistent with those of previous studies showing that HIF-1a activation is minimal under very low oxygen concentrations, 17 such as 0.1% used in the current study. Brain ischemia has also been reported to activate the eukaryotic initiation factor 2a kinase PERK, an ER-stress sensor. 18 Interestingly, CypB was also induced by brain ischemia ( Figure 5 ). Furthermore, overexpression of CypB significantly prevented hypoxiainduced cell death, whereas the cell death was augmented in the CypB-knockdown cells (Figure 7) .
Here, we showed that ubiquitination of CHOP was regulated by cooperative binding of CypB and p300 to the N-terminal portion of CHOP. CHOPDN36 was not readily ubiquitinated, indicating that the region up to a.a 35 of CHOP was essential for its degradation. The potential mechanism underlying the cytoprotective role of CypB in hypoxia is summarized in Figure 7h . Hypoxia induces CypB and CHOP through ATF6 and ATF4, respectively. Association of CypB, CHOP, and p300 promotes the ubiquitination of CHOP, a proapoptotic molecule. This process suppresses hypoxiainduced cell death.
Chaperone function has been traditionally linked to the folding and assembly of proteins. [19] [20] [21] However, in recent years multiple chaperone-assisted degradation pathways have also emerged, including chaperone-assisted proteasomal degradation, chaperone-assisted selective autophagy, and chaperone-mediated autophagy. 22 We also have showed in detail a novel CypB-CHOP complex that enhances the rate of ubiquitination of CHOP. Although the associations between molecular chaperones and the ubiquitin-proteasome system seem to be critical for cytoprotection in response to ER stress, the relationship between chaperone-proteasome interaction and cellular physiological events remains to be explored in detail. Furthermore, many more studies are required to fully understand the exact role of CypB in regulating the stability of other possible binding proteins. Nonetheless, taken together, these results make CypB an attractive therapeutic target, the inhibition of which could potentially upregulate the expression of CHOP and other pro-apoptotic proteins to retard the growth of human tumor cells. 0 ,6 0 -Diamidino-2 0 -phenylindole dilactate, AEBSF, antiglucose-related protein 78/Bip, anti-actin, anti-Bax, anti-Bcl-2, PARP, antia-actinin, anti-p300, IgG, HA-tag, protein G/A bead, anti-GST and ECL Western blotting kit was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Cyclophilin B, calnexin, ATF6, and ATF4 were purchased from Abcam (Cambridge, UK). Anti-Myc monoclonal antibody (9E10) was from Roche Applied Science (Mannheim, Germany). Ubiquitin and MG132 were purchased from Assay Designs (Ann Arbor, MI, USA). Apo-BrdU In Situ DNA Fragmentation Assay Kit was purchased from BioVision (Mountain View, CA, USA). Other chemical reagents were obtained from Sigma-Aldrich.
Plasmid constructions. A cDNA encoding the C-terminal 216 amino acids of WT CypB and PPIase-defective CypB R95A mutant was subcloned into the pcDNA vector (Invitrogen) between HindIII and EcoRV sites for protein expression, which tagged the protein with an HA-tag at the C-terminal end. Flag-CHOP, Flag-ATF4, Flag-XBP1 and Flag-CypB were subcloned into pCMV-Taq 2B flag vector using BamHI and XhoI restriction sites. GST-CypB and CypB series region reporter plasmids have been described previously. 10 The active-ATF6 expression vector was kindly provided by Dr. Kyung Ho Lee (Konkuk University, Seoul, Korea). The human CHOP promoter reporter constructs were kindly provided by Dr. P Fafournoux (Unité Nutrition Humaine, INRA de Theix, Champanelle, France). HA-p300 and HA-ubiquitin expression vectors were kindly provided by Dr. J Ha (Kyung Hee University, Seoul, Korea). The plasmids pcDNA3.1-Myc-CHOP, Figure 6 ATF6 mediates hypoxia-induced transcriptional upregulation of CypB. (a) AGS cells were transfected with the pGL3-CypB-250 plasmids, active form-ATF6 (p50ATF6), and spliced XBP1 (sXBP1) expression plasmids. After transfection, the cells were assayed for luciferase activity (upper panel) and western blot (lower panel). (b) Effect of site-specific mutagenesis of ATF6 on the luciferase activity. AGS cells were transiently transfected with the WT and mutant form CypB-250 plasmids. After transfection, cells were exposed to normoxic or hypoxic conditions for 24 h and subjected to the luciferase assay. (c) ATF6 binds to the region of the CypB promoter containing the CRE. Protein-DNA complexes from AGS cells exposed to hypoxia for 48 h were subjected to ChIP analysis. Where indicated, non-specific IgG was used as a control in the IP and subjected to RT-PCR (left panel) or real-time PCR (right panel). (d) AGS cells treated with siCon or siATF6 were cultured under hypoxic conditions for 24 h and analyzed using the luciferase assay (left panel) and RT-PCR (right panel). (e) AGS cells were exposed to hypoxia for the indicated times in the absence or presence of 300 mM AEBSF for 4 h by real-time PCR. (f) AGS cells were transfected with the pGL3-CypB-250 plasmid, exposed to hypoxia for the indicated times in the absence or presence of 300 mM AEBSF for 4 h, and followed by the luciferase assay (left panel) and western blot (right panel). (g) AGS cells were exposed to hypoxia for 48 h in the absence or presence of 300 mM AEBSF for 4 h, and cell death rate was evaluated using the trypan blue exclusion assay and expressed as a percentage of the stained cells. (h) AGS cells were exposed to hypoxia for 48 h and incubated in the absence or presence of 300 mM AEBSF for 4 h, and binding of ATF6 to the element A (irrelevant site) and B (CRE site) regions of the CypB promoter was analyzed by ChIP. Quantitative analysis of all the bands is shown using ImageJ program. Bars represent means ± s.d.; *Po0.05, **Po0.01
Animals. All protocols were approved by the Institutional Animal Care and Use Committee of Kyung Hee University. Animals were subjected to global ischemia by temporary BCCAO (7 min) or to sham surgery, followed by reperfusion, as described previously. 23 The sections were analyzed using an LSM510 confocal laser microscope (Carl Zeiss, Oberkochen, Germany).
RT-PCR and real-time PCR. Total cellular RNA was extracted from cells using the TRIzol reagent (Invitrogen). A cDNA was synthesized from 2 mg of total RNA using M-MLV reverse transcriptase (Fermentas, Hanover, MD, USA). 0 . PCR products were analyzed by agarose gel electrophoresis and visualized using ethidium bromide. The signals were quantitated using Image J software (National Institutes of Health (NIH), Bethesda, MD, USA). Real-time PCR was performed using an ABI prism 7300 Sequence Detection System (Applied Biosystems, Branchburg, NJ, USA) with SYBRGreen PCR Master Mix (Applied Biosystems). The PCR reaction was carried out for 40 thermal cycles. Expression of the target gene was analyzed by an absolute quantification method and normalized using b-actin levels.
Luciferase assay. The CypB promoter sequence was analyzed using Genomatrix MatInspector (http://www.genomatix.de). One ERSE candidate was located at À 222 bp, approximately À 209 bp from the CypB ORF. AGS cells were transfected with 0.8 mg of the pGL3 basic-derived plasmids together with the internal control plasmid, pCMV-b-galactosidase (Promega, Madison, WI, USA). Luciferase and b-gal activities were measured using 50 ml of each cell lysate using a fluorescence microplate reader, and the luciferase activity was normalized on the basis of b-galactosidase values. Transfection experiments were performed in triplicates and repeated at least three times.
GST pull-down assay. GST fusion proteins, GST, and GST-CypB were expressed in an Escherichia coli DH5a strain and affinity purified on glutathionesepharose 4B beads. Isopropyl-1-thio-b-D-galactopyranoside was added in a growing exponential bacterial culture to a final concentration of 1 mM and incubated for 4 h at 37 1C. Whole-cell lysates from HEK293 QBI cells were incubated with total cells extracted and treated for 24 h. After extensive washes, SDS-PAGE sample buffer was added to the beads, boiled, and subjected to SDS-PAGE. Fractionated proteins were visualized by western blot.
Western blot and coimmunoprecipitation. The cells were washed twice with cold phosphate-buffered saline (PBS) on ice and harvested by scraping with a rubber policeman. The cells were pelleted by centrifugation at 4 1C and resuspended directly into a lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% Igepal CA-630, 2 mM EDTA, 10 mM NaF, 2 mM Na 3 VO 4 , and 0.01% protease inhibitor cocktail). Cell lysates were subjected to SDS-PAGE and transferred to a nitrocellulose membrane. After blocking in 5% skimmed milk and tris-buffered saline with 0.1% Tween-20, signals were detected and analyzed by a Kodak X-OMAT 2000 image analyzer (Rochester, NY, USA). For immunoprecipitation experiments, cell lysates were precleared with protein G/A beads and subsequently incubated for 1-2 h with protein G/A beads covalently coupled with anti-CypB, anti-CHOP, and anti-p300. Immune complexes were washed four times with cell extraction buffer. Eluted samples or whole-cellular lysates were resolved by SDS-PAGE and proteins were detected by western blot using the indicated antibodies. Densitometric analysis was performed using ImageJ software. Unless otherwise specified, actin protein was immunoblotted in order to normalize the quantity of sample protein.
Ubiquitination assay. The HEK293 QBI cells were transiently cotransfected with indicated plasmids and were treated with 20 mM MG132 for 4 h before harvesting. Cells were lysed with lysis buffer and immunoprecipitated with anti-CHOP or HA antibodies. The ubiquitination reaction mixtures were collected by centrifugation and washed three times with lysis buffer. The samples were then subjected to SDS-PAGE followed by western blot.
Site-directed mutagenesis. Site-directed mutagenesis of the CypB promoter (pGL-250) region was performed using a QuickChange Site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the instruction manual. The pGL3-250/CypB vector was used as a template DNA and PCR based site-directed mutagenesis were as follows: ATF6 binding site (sense 5 0 -GA GCAATAACACAGCAACCACCC-3 0 , and anti-sense 5 0 -CTCGTTATTGTGTC GTTGGTGGG-3 0 ). The underlined letters represent the mutated sequence for the site-directed mutagenesis. PCR was performed using two antiparallel primers with the required nucleotide substitutions and pGL3-250/CypB plasmid as a template. The PCR product was then treated with DpnI endonuclease. The sequences of the mutation constructs were confirmed by DNA sequencing.
ChIP assay. ChIP assay was conducted using the ChIP assay protocol (Upstate, Lake Placid, NY, USA) according to the manufacturer's instructions. Primers were as follows: For element A, forward, 5
RNA interference. Double-stranded RNA duplexes corresponding to human
, and control siRNA (5 0 -GCGCGCUUUGUAGGAUUCG-3 0 ) were designed. They were purchased from Dharmacon (Chicago, IL, USA). Each well was incubated for 48 h with 100 pmol using lipofectamine 2000 reagents (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendations. The cells were then washed off the plates and the transfected cells were placed in a serum-free medium, after which they were subjected to various treatments.
Immunofluorescence microscopy. Immunofluorescence microscopy was performed as described previously. 16 Images were taken using the laser-scanning confocal microscope. For quantification, cells for each condition were analyzed in three sets.
Clonogenic assay. Long-term survival was determined by a colony-forming assay. A total of 1 Â 10 3 cells were plated onto 60-mm dishes. At 24 h after plating, cells were transfected with either an empty vector (pcDNA3) or HA-CypB expression vector and incubated for 2 days under hypoxia (0.1% O 2 ) conditions. Cell monolayers were rinsed twice and then fresh medium was added. After 10 Figure 7 Overexpression of CypB suppresses hypoxia-induced apoptosis by ER stress-dependent pathways. (a) AGS cells transfected with HA-CypB (4 mg), were exposed to hypoxia for 48 h. Cells were fixed, permeabilized, and followed by the TUNEL assay. TUNEL-positive cells were quantified and plotted (upper panel). The expression levels of HA-CypB, cleaved-caspase3 and cleaved-PARP protein were analyzed by western blot (lower panel). (b) AGS cells were transfected with empty pcDNA (4 mg) and HA-CypB (4 mg), and then exposed to hypoxia for 48 h. Cells were harvested and subjected to propidium iodide staining. The apoptosis rate was measured by sub-G1 DNA contents using FACS. (c) Attenuation of hypoxia-induced apoptosis by overexpression of CypB (4 mg) was determined by the clonogenic assay. Surviving fractions were determined based on plating efficiencies. (d) Knockdown efficiency of siCypB was determined by western blot. Cell death rate was evaluated using the trypan blue exclusion assay and expressed as a percentage of the stained cells. (e) AGS cells treated with negative control siCon or siCypB were cultured under hypoxia for 48 h and subjected to western blot analysis for the evaluation of proteins involved in apoptotic cell death. The expression levels of CypB, cleaved-caspase 3, cleaved-PARP, Bax, Bcl-2, GRP78, and p-elF2a were analyzed. Actin was used as a loading control. (f) CHOP activation in CypB knockdown-induced apoptosis under hypoxia. After exposure to hypoxic conditions for 48 h, cells were stained with anti-CypB (green), anti-CHOP (red) and followed by nuclear staining with DAPI (blue). Bars, 20 mm. (g) AGS cells transfected with negative control siRNA and CypB siRNA for 48 h were exposed to normoxic or hypoxic conditions for 48 h and the double-knockdown efficiency of siCypB and siCHOP was determined by the trypan blue exclusion assay and expressed as a percentage of the stained cells. 
Po0.05
The role of CypB in CHOP ubiquitination K Jeong et al days, the colonies were fixed with methanol and stained with 0.1% crystal violet solution. After 30 min, the absorbance of the reaction mixtures was measured at 595 nm using a fluorescence microplate reader (Bio-Rad, Hercules, CA, USA).
TUNEL assay. The TUNEL assay was conducted using the Apo-BrdU In Situ DNA Fragmentation Assay Kit following the protocol of the supplier. The TUNEL reaction was performed according to the manufacturer's instructions. The number of apoptotic cells was expressed as a percentage of the total cells counted from five random fields for each cover slip.
Stable cell line development. For the development of pcDNA3 and WT CypB, AGS and HeLa cells were transfected with pcDNA3 and HA-tagged CypB. Two days post transfection, cells were selected with 1 mg/ml G418 sulfate until distinct colonies emerged. Colonies were propagated and examined for CypB and HA expression levels.
Apoptosis assay. For FACS analyses of cell cycle and apoptosis, cells were fixed in 70% (v/v) ethanol in PBS and then stored at 4 1C. The fixed cells were washed in PBS, incubated with 1 ml of a solution containing RNase A (50 mg/ml) and propidium iodide (50 mg/ml) solution for 30 min at room temperature. At least 1 Â 10 4 cells were collected and analyzed by flow cytometry (Beckman-Coulter, Brea, CA, USA). Percentages of cells in sub-G1 were calculated with Multicycle for Windows software (Beckman-Coulter). Apoptotic cell death was determined by the trypan blue exclusion assay. The hypoxic cells were trypsinized and then centrifuged at 1000 Â g for 5 min. Both dead cells floating in the medium and the cells attached to the plate were recovered and resuspended in 500 ml medium. The trypan blue exclusion assay was performed using the Vi-cell TM XR (Beckman-Coulter).
Statistical analysis. The results were expressed as means±s.d. from at least three independent experiments. Statistical analyses were conducted using Student's t-tests. By convention, a P-value of o0.05 was considered statistically significant.
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